Spots Global Cancer Trial Database for biochemical failure
Every month we try and update this database with for biochemical failure cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy | NCT00096551 | Prostatic Neopl... | Recombinant Vac... Recombinant Fow... Recombinant Fow... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy | NCT03706508 | Prostate Cancer Erectile Dysfun... Complication of... Urinary Inconti... | Robot-assisted ... | 40 Years - 80 Years | Hospital de Clinicas de Porto Alegre | |
| Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer | NCT03207139 | Latent Cancer P... | Ga-68 PSMA liga... | 20 Years - 90 Years | Chang Gung Memorial Hospital | |
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | NCT01350180 | Prostate Cancer | - | Sir Mortimer B. Davis - Jewish General Hospital | ||
| Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer | NCT03207139 | Latent Cancer P... | Ga-68 PSMA liga... | 20 Years - 90 Years | Chang Gung Memorial Hospital | |
| Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy | NCT01834001 | Prostatic Neopl... Prostate Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer | NCT03207139 | Latent Cancer P... | Ga-68 PSMA liga... | 20 Years - 90 Years | Chang Gung Memorial Hospital | |
| Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy | NCT01834001 | Prostatic Neopl... Prostate Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| FOcal RECurrent Assessment and Salvage Treatment | NCT01883128 | Progression of ... | Whole Body MRI Focal Salvage T... MRI Targeted bi... | 18 Years - | University College London Hospitals | |
| Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy | NCT01834001 | Prostatic Neopl... Prostate Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Effectiveness of Localized Prostate Cancer Treatments | NCT01492751 | Prostate Cancer | Quality of life... Radical retropu... External beam r... Prostate Brachy... | - | Fundacion IMIM | |
| Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy | NCT00439751 | Prostate Cancer | Goserelin Aceta... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy | NCT01834001 | Prostatic Neopl... Prostate Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy | NCT00439751 | Prostate Cancer | Goserelin Aceta... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | NCT01350180 | Prostate Cancer | - | Sir Mortimer B. Davis - Jewish General Hospital | ||
| Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | NCT01350180 | Prostate Cancer | - | Sir Mortimer B. Davis - Jewish General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
